OREANDA-NEWS. Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter fiscal year 2015 on Thursday, October 22, 2015. The Company has scheduled a conference call for that same day, Thursday, October 22, 2015 at 11:00am ET (4:00pm BST) to discuss the results of the quarter. 

Interested parties can access the call by dialing:

            USA:                1-888-243-4451

            International:   1-412-542-4135

            Conference ID #:        10074555

A simultaneous webcast of the call can be accessed at:


A replay of the call can be accessed until October 29, 2015 by dialing:

               USA:                      1-877-344-7529

               International:         1-412-317-0088

               Conference ID #:   10074555

The webcast of the call will be available for 30 days at: https://www.webcaster4.com/Webcast/Page/1135/11146


Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide.